Then, to evaluate how high Gal-3 expression could lead to poor survival in GBM, we performed a differential gene expression analysis based on Gal-3high versus Gal-3low in GBM patients in several datasets (Supplementary Table 2). This evidence concerns the gene LGALS3 and glioblastoma.